Daiichi Sankyo

Uncategorized

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastatic Breast Cancer

By:The Tutu Team | 8th September 2017

Author: Barbara Jacoby / Source: Let Life Happen From: PR Newswire — Breakthrough...